Krüppel cripples prostate cancer: KLF6 progress and prospects.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis.Cell proliferation · 2019
   Article
2. The KLF6 splice variant KLF6-SV1 promotes proliferation and invasion of non-small cell lung cancer by up-regultating PI3K-AKT signaling pathway.Journal of Cancer · 2019
   Article
3. KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer.Cancer management and research · 2018
   Article
4. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.Journal of physiology and biochemistry · 2016
   Article
5. Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways.Frontiers in oncology · 2016
   Review
6. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.International journal of clinical and experimental pathology · 2015
   Article
7. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.International journal of clinical and experimental pathology · 2015
   Article
8. Mutations and Krüppel-like factor 6 (KLF6) expression levels in breast cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
   Article
9. Decreased Kruppel-like factor 4 (KLF4) expression may correlate with poor survival in gastric adenocarcinoma.Medical oncology (Northwood, London, England) · 2013
   Article
10. MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
11. Effects of Kruppel-like factor 6 on osteosarcoma cell biological behavior.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
12. Prostate-specific Klf6 inactivation impairs anterior prostate branching morphogenesis through increased activation of the Shh pathway.The Journal of biological chemistry · 2009
    Article
13. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data.Diabetes, obesity & metabolism · 2009
    Article
14. Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.Molecular carcinogenesis · 2008
    Article
15. DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function.Oncogene · 2008
    Article
16. The Pathobiology of Krüppel-like Factors in Colorectal Cancer.Current colorectal cancer reports · 2008
    Article
17. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.Oncogene · 2007
    Article
18. Establishment of transgenic mice carrying gene encoding human zinc finger protein 191.World journal of gastroenterology · 2004
    Article

Corrections and comments

• Comment on
  Deletion, mutation, and loss of expression of KLF6 in human prostate cancer.2003

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as